HomeVTRS • NASDAQ
Viatris Inc
$11.67
After Hours:
$11.67
(0.00%)0.00
Closed: Jan 10, 4:30:00 PM GMT-5 · USD · NASDAQ · Disclaimer
StockUS listed securityUS headquartered
Previous close
$11.96
Day range
$11.57 - $11.88
Year range
$9.93 - $13.62
Market cap
13.93B USD
Avg Volume
8.84M
P/E ratio
-
Dividend yield
4.11%
Primary exchange
NASDAQ
CDP Climate Change Score
B
Financials
Income Statement
Revenue
Net income
(USD)Sep 2024Y/Y change
Revenue
3.75B-4.84%
Operating expense
1.09B-6.46%
Net income
94.80M-71.41%
Net profit margin
2.53-69.92%
Earnings per share
0.75-4.94%
EBITDA
1.19B-4.80%
Effective tax rate
-4.75%
Total assets
Total liabilities
(USD)Sep 2024Y/Y change
Cash and short-term investments
2.05B47.34%
Total assets
44.75B-8.18%
Total liabilities
24.96B-10.46%
Total equity
19.79B
Shares outstanding
1.19B
Price to book
0.72
Return on assets
2.89%
Return on capital
3.58%
Net change in cash
(USD)Sep 2024Y/Y change
Net income
94.80M-71.41%
Cash from operations
826.50M-1.04%
Cash from investing
1.75B3,283.79%
Cash from financing
-1.64B-1,576.95%
Net change in cash
961.60M41.33%
Free cash flow
3.11B303.69%
About
Viatris Inc. is an American global pharmaceutical and healthcare corporation headquartered in Canonsburg, Pennsylvania. The corporation was formed through the merger of Mylan and Upjohn, a legacy division of Pfizer, on November 16, 2020. The name of the corporation comes from the Latin words via, meaning path, and tris, which means three, referring to the path to three main objectives the corporation set: expanding access to medicines, meeting patient needs through innovation, and earning the trust of the healthcare community. Viatris ranked 254th on the 2021 Fortune 500 rankings of the largest United States corporations based on its 2020 total revenue. Wikipedia
Founded
Nov 16, 2020
Employees
32,000
Search
Clear search
Close search
Google apps
Main menu